Du är här


Weifa ASA: Weifa ASA - Acquisition of Asan completed

Oslo, 15 January 2015

Reference is made to the stock exchange release on 17 December 2015 regarding
the acquisition of the outstanding shares of Cederroth AS, the company that
owns the leading intimate care brand Asan and its Swedish counterpart Sana.
The transaction is approved by the Competition Authorities and completed
today through the final settlement of the purchase consideration.

For further information, please contact:

Kathrine Gamborg Andreassen


+47 951 78 680


Simen Nyberg-Hansen


+47 9820 6355


About Weifa:

Weifa is Norway's leading Consumer health company. Weifa supplies
pharmaceutical products and lifestyle products that address the essential
needs of consumers, customers and professional partners. The Company has a
strong position in Norway and is the market leader in pain relief, with
well-established brands such as Paracet and Ibux, and is also present in
other key areas such as dietary supplements and treatment for colds and
respiratory problems. Weifa is listed on the Oslo Stock Exchange and has its
head office in Oslo. In 2014, the Group had a turnover of approximately NOK
316m (after adjusting for the divestment of the B2B business). The company
currently has approximately 30 employees.

This information is subject to the disclosure requirements pursuant to section 5-12 of the Norwegian Securities Trading Act.


This announcement is distributed by NASDAQ OMX Corporate Solutions on behalf of NASDAQ OMX Corporate Solutions clients.
The issuer of this announcement warrants that they are solely responsible for the content, accuracy and originality of the information contained therein.
Source: Weifa ASA via Globenewswire


Författare WKR

Tala om vad ni tycker

Tala om vad ni tycker

Ni är just nu inne på en betaversion av nya aktiespararna. Lämna gärna feedback på vad ni tycker i formuläret nedan.